Form 4 for NVNO enVVeno Medical Corp
Accepted 2022-06-28 00:00:00 ET · period of report 2022-06-27 · accession 0001493152-22-017957 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-28 | 2022-06-27 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | P - Purchase | $3.80 | +2,500 | 210.2K | +1% | +$9,500 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | P | A | 2,500 | $3.80 | 210,236 | D | — | — |